Bench-to-bedside: NIMH research leads to brexanolone, first-ever drug specifically for postpartum depression
Approximately 1 in 9 women in the United States experiences symptoms.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Depression | National Institutes of Health (NIH) | Postnatal Depression | USA Health | Women